Improving the quality of pharmacotherapy in elderly primary care patients through medication reviews: A randomised controlled study

Drugs and Aging

Volumn 30, Issue 4, 2013, Pages 235-246

  Milos, Veronica ^a,b,c   Rekman, Eva ^d   Bondesson, Åsa ^c,e   Eriksson, Tommy ^c,f   Jakobsson, Ulf ^b   Westerlund, Tommy ^g,h   Midlöv, Patrik ^b  

^a Laröd Health Care Centre   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY   (Sweden)

^d Brösarp Health Care Centre   (Sweden)

^e Department of Medicines Management and Informatics ^*  (Sweden)

^f Apoteket AB   (Sweden)

^g MEDICAL PRODUCTS AGENCY   (Sweden)

^h UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PSYCHOTROPIC AGENT;

AGED; ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD; NURSING HOME; PATIENT CARE; PHARMACIST; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEDEN; SYMPTOM ASSESSMENT; TOTAL QUALITY MANAGEMENT;

EID: 84876926541     PISSN: 1170229X     EISSN: 11791969     Source Type: Journal    
DOI: 10.1007/s40266-013-0057-0     Document Type: Article

References (44)

1. Shi S, Morike K, Klotz U. The clinical implications of ageing for rational drug therapy. Eur J Clin Pharmacol. 2008;64(2):183-99.
2. Noble RE. Drug therapy in the elderly. Metabolism. 2003;52(10 Suppl 2):27-30. (Pubitemid 37345190)
3. Midlov P, Eriksson T, Kragh A. Drug-related problems in the elderly [online] Chapter 1, Aging and Drugs 2009: 4. Available from URL: http://www.springerlink.com.ludwig.lub.lu.se [Accessed 2012 Nov 19].
4. Hajjar ER, Cafiero AC, Hanlon JT. Polypharmacy in elderly patients. Am J Geriatr Pharmacother. 2007;5(4):345-51.
5. Strand LM, Morley PC, Cipolle RJ, Ramsey R, Lamsam GD. Drug-related problems: their structure and function. DICP. 1990;24(11):1093-7.
6. American Geriatrics Society 2012 Beers Criteria Update Expert Panel. American Geriatrics Society updated Beers Criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc. 2012;60(4):616-31.
7. The Swedish National Board of Health and Welfare. Indikatorer för god läkemedelsterapi hos äldre (publication no.: 2010-6-29) [in Swedish]. Available from URL: http://www.socialstyrelsen.se [Accessed 2012 Nov 16].
8. Johnell K, Fastbom J. Multi-dose drug dispensing and inappropriate drug use: a nationwide register-based study of over 700,000 elderly. Scand J Prim Health Care. 2008;26(2):86-91. (Pubitemid 351877032)
9. Ruths S, Straand J, Nygaard HA. Multidisciplinary medication review in nursing home residents: what are the most significant drug-related problems? The Bergen District Nursing Home (BEDNURS) study. Qual Saf Health Care. 2003;12(3):176-80. (Pubitemid 36723943)
10. Midlov P, Bondesson A, Eriksson T, et al. Effects of educational outreach visits on prescribing of benzodiazepines and antipsychotic drugs to elderly patients in primary health care in southern Sweden. Fam Pract. 2006;23(1):60-4.
11. Midlov P, Deierborg E, Holmdahl L, et al. Clinical outcomes from the use of Medication Report when elderly patients are discharged from hospital. Pharm World Sci. 2008;30(6):840-5.
12. Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18(1):63-77. (Pubitemid 32182133)
13. Pharmaceutical Care Network Europe. PCNE Guidelines for Retrospective Medication Review in Pharmacy V0, The official PCNE definition 2012. Available from: http://www.pcne.org 2012 [Accessed 2012 June 15].
14. Westerlund T, Marklund B. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems. J Clin Pharm Ther. 2009;34(3):319-27.
15. Roberts MS, Stokes JA, King MA, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51(3):257-65. (Pubitemid 32396417)
16. Brulhart MI, Wermeille JP. Multidisciplinary medication review: evaluation of a pharmaceutical care model for nursing homes. Int J Clin Pharm. 2011;33(3):549-57.
17. Kragh A. Two out of three persons living in nursing homes for the elderly are treated with at least ten different drugs. A survey of drug prescriptions in the northeastern part of Skane [in Swedish]. Lakartidningen. 2004;101(11): 994-6, 9.
18. Hellstrom LM, Bondesson A, Hoglund P, et al. Impact of the Lund Integrated Medicines Management (LIMM) model on medication appropriateness and drug-related hospital revisits. Eur J Clin Pharmacol. 2011;67(7):741-52.
19. Schmidt I, Claesson CB, Westerholm B, et al. The impact of regular multidisciplinary team interventions on psychotropic prescribing in Swedish nursing homes. J Am Geriatr Soc. 1998;46(1):77-82. (Pubitemid 28037677)
20. Hedström MLB, Hulter Åsberg K. PHASE-20: a new instrument for assessment of possible therapeutic drug-related symptoms among elderly in nursing homes [in Swedish]. Nord J Nurs Res Clin Stud/Vård i Norden. 2009;29(4):9-14.
21. Anatomical Therapeutic Chemical Classification System [online]. Available from URL: http://www.who.int/classifications/atcddd/en/ [Accessed 2012 6th June].
22. Cipolle RJ, Strand LM, Morley PC. Pharmaceutical care practice. New York: McGraw-Hill; 1998.
23. Bennett DA. How can I deal with missing data in my study? Aust N Z J Public Health. 2001;25(5):464-9. (Pubitemid 32952052)
24. Crotty M, Halbert J, Rowett D, et al. An outreach geriatric medication advisory service in residential aged care: a randomised controlled trial of case conferencing. Age Ageing. 2004;33(6):612-7. (Pubitemid 39504296)
25. Davidsson M, Vibe OE, Ruths S, et al. A multidisciplinary approach to improve drug therapy in nursing homes. J Multidiscip Healthc. 2011;4:9-13.
26. Liu GG, Christensen DB. The continuing challenge of inappropriate prescribing in the elderly: an update of the evidence. J Am Pharm Assoc (Wash). 2002;42(6):847-57.
27. Finkers F, Maring JG, Boersma F, et al. A study of medication reviews to identify drug-related problems of polypharmacy patients in the Dutch nursing home setting. J Clin Pharm Ther. 2007;32(5):469-76. (Pubitemid 47404286)
28. Higashi T, Shekelle PG, Solomon DH, et al. The quality of pharmacologic care for vulnerable older patients. Ann Intern Med. 2004;140(9):714-20.
29. Steinman MA, Landefeld CS, Rosenthal GE, et al. Polypharmacy and prescribing quality in older people. J Am Geriatr Soc. 2006;54(10):1516-23. (Pubitemid 44564145)
30. Meredith S, Feldman P, Frey D, et al. Improving medication use in newly admitted home healthcare patients: a randomized controlled trial. J Am Geriatr Soc. 2002;50(9):1484-91. (Pubitemid 35024639)
31. Spinewine A, Schmader KE, Barber N, et al. Appropriate prescribing in elderly people: how well can it be measured and optimised? Lancet. 2007;370(9582):173-84. (Pubitemid 47049724)
32. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet. 2007;370(9582):185-91. (Pubitemid 47042897)
33. Holland R, Desborough J, Goodyer L, et al. Does pharmacist-led medication review help to reduce hospital admissions and deaths in older people? A systematic review and meta-analysis. Br J Clin Pharmacol. 2008;65(3):303-16. (Pubitemid 351316922)
34. Gallagher P, Barry P, Mahony D. Inappropriate prescribing in the elderly. J Clin Pharm Ther. 2007;32(2):113-21. (Pubitemid 46449699)
35. Bondesson A, Holmdahl L, Midlov P, et al. Acceptance and importance of clinical pharmacists' LIMM-based recommendations. Int J Clin Pharm. 2012;34(2):272-6.
36. Bergkvist Christensen A, Holmbjer L, et al. The process of identifying, solving and preventing drug related problems in the LIMM-study. Int J Clin Pharm. 2011;33(6):1010-8.
37. Zermansky AG, Alldred DP, Petty DR, et al. Clinical medication review by a pharmacist of elderly people living in care homes - randomised controlled trial. Age Ageing. 2006;35(6):586-91. (Pubitemid 44614153)
38. Stuijt CC, Franssen EJ, Egberts AC, et al. Appropriateness of prescribing among elderly patients in a Dutch residential home: observational study of outcomes after a pharmacist-led medication review. Drugs Aging. 2008;25(11):947-54.
39. Halvorsen KH, Ruths S, Granas AG, et al. Multidisciplinary intervention to identify and resolve drug-related problems in Norwegian nursing homes. Scand J Prim Health Care. 2010;28(2):82-8.
40. Chen TF, de Almeida Neto AC. Exploring elements of interprofessional collaboration between pharmacists and physicians in medication review. Pharm World Sci. 2007;29(6):574-6. (Pubitemid 47594181)
41. de Almeida Neto AC, Chen TF. When pharmacotherapeutic recommendations may lead to the reverse effect on physician decision-making. Pharm World Sci. 2008;30(1):3-8. (Pubitemid 350172650)
42. Bernabei R, Gambassi G, Lapane K, et al. Characteristics of the SAGE database: a new resource for research on outcomes in long-term care. SAGE (Systematic Assessment of Geriatric drug use via Epidemiology) Study Group. J Gerontol A Biol Sci Med Sci. 1999;54(1):M25-33.
43. Kragh A, Rekman E. Remote drug-review for better use of pharmaceuticals among the elderly [in Swedish]. Lakartidningen. 2005;102(15):1143, 5-6, 9.
44. Holland R, Smith R, Harvey I. Where now for pharmacist led medication review? J Epidemiol Community Health. 2006;60(2):92-3. (Pubitemid 43131924)